Macmillan invests in Neutrocheck device for home-testing neutropenic sepsis
/
DateFeb 15 2023
Macmillan Cancer Support, the cancer charity, has invested in Neutrocheck – a portable device and accompanying app in development from 52 North Health – with... Read More →



















